Skip to main content

UAS™-A Urine Preservative for Oncology Applications.

Jordaens S, Arora A, MacDonald KW, Wood C, Hendrickx JO, Zwaenepoel K, Deben C, Tjalma W, Pauwels P, Beyers K, Vankerckhoven V

Publication: Cancers (Basel) (2023) • Vol 15PMID: 37370729View on PubMed

Purpose

This paper compared the stability of human, microbial, and host-cell cell-free DNA (cfDNA) in unpreserved urine and urine preserved with UAS after storage at room temperature and freeze-thaw cycling. The paper also compared the concentration and percentage of cfDNA extracted using three different kits from UAS preserved urine of male and female volunteers, cancer patients, and pregnant women.

Conclusion

Compared to urine aliquots processed immediately, those stored for 7 days at room temperature had significantly less β-globin (human) cfDNA and more microbial (16S) cfDNA. Storage of urine for 7 days at room temperature resulted in much larger differences in microbial, host-cell, and B-globin cfDNA CT values relative to immediately processed controls when specimens were not preserved than when they were preserved with UAS. UAS preserved urine also showed significantly smaller changes in average CT for β-globin and TS143 cfDNA after 3 freeze-thaw cycles than unpreserved urine.  Interestingly, delayed processing did not affect the cfDNA fragment size profile.  The concentration of cfDNA was higher in urine from females than males, regardless of diagnosis. Extraction of cfDNA with the Norgen Urine Kit resulted in significantly lower cfDNA concentrations than extraction with MaxWell RSC or QIAamp CNA Kits. There was no effect of extraction method or patient gender on the percentage cfDNA.

Studies (2)

Purpose

This study compared the stability of human, microbial, and host-cell cfDNA in unpreserved urine and urine preserved with UAS after storage of urine for 7 or 14 days at room temperature and after 0 or 3 freeze-thaw cycles. To investigate the effects of delayed processing, first-morning urine was collected from 7 volunteers (five females and 2 males; diagnosis not specified) into standard urine collection cups or Colli-Pee® FV-5020 containers. Urine specimens were aliquoted and transported on ice packs to the laboratory where they were centrifuged immediately or after 7 days at room temperature (20-26°C); supernatants were frozen at -80°C until cfDNA extraction. To evaluate if UAS can preserve cfDNA in urine, first morning urine was collected from 42 males and 42 females into Colli-Pee® FV-5020 containers. Fourteen pooled specimens from females and males were created by pooling urine specimens from three patients. Each urine pools were split and UAS preservative was added to half while the other half remained unpreserved. The preserved and unpreserved urine was then aliquoted and stored at room temperature for 0, 7, or 14 days or subjected to 0 or 3 freeze-thaw cycles (-20°C to 40°C; ≥ 3 h at each temperature) before centrifugation. After relevant storage, urine aliquots were centrifuged at 3800 x g for 20 min, filtered through a 0.8 µm filter, and stored at -80°C until cfDNA extraction. Urine was thawed at 37°C, and cfDNA was extracted from the supernatant using the QIAamp Circulating Nucleic Acid Kit and from the pellet (UAS experiments only) using the PowerFecal Pro DNA Kit. cfDNA was quantified by real-time PCR amplification of 16S Bacterial rDNA, TS143, and β-globin. DNA fragment size was profiled using a High-Sensitivity D5000 DNA ScreenTape machine.

 

Summary of Findings

Compared to urine aliquots processed immediately, urine stored for 7 days at room temperature had significantly less β-globin (human) cfDNA (average CT 6.58 cycles higher, P<0.0001) and more microbial (16S) cfDNA (average CT 2.83 cycles lower, P=0.0367). When stored for 7 days at room temperature, the change in CT relative to unstored specimens for microbial, host-cell (TS143) and β-globin cfDNA were much higher in unpreserved urine than urine preserved with UAS (-7.64 versus 0.30 cycles, P=0.0002; 6.05 versus 0.07 cycles, P<0.0001; and 8.25 versus 0.18 cycles, P<0.0001, respectively).  The change in CT for TS143 and β-globin cfDNA in specimens stored for 14 days was also higher in unpreserved urine than urine preserved with UAS (9.61 versus -0.01 cycles, P<0.0001; and 7.68 versus 0.33 cycles, P<0.0001, respectively). UAS preserved urine also showed significantly smaller changes in average CT for β-globin and TS143 cfDNA after 3 freeze-thaw cycles than unpreserved urine (0.32 versus 7.49 cycles, P<0.0001; and 0.31 versus 6.68 cycles, respectively P<0.0001).  Interestingly, delayed processing did not affect the cfDNA fragment size profile.

  • Biospecimens

    FluidUrine
  • Preservation Types

    Other PreservativeNone (Fresh)
  • Diagnoses

    Not specified
    Normal
  • Platforms

    DNAAutomated electrophoresis/Bioanalyzer
    DNAReal-time qPCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen Aliquots and ComponentsCentrifugation
    Centrifugation delays investigated
    Biospecimen PreservationType of fixation/preservation
    None (fresh)
    UAS
    StorageFreeze/thaw cycling
    0 cycles
    3 cycles
    StorageTime at room temperature
    0 days
    14 days
    7 days
    Real-time qPCR SpecificTargeted nucleic acid
    Host cell cfDNA (TS143)
    Human cfDNA (β-globin)
    Microbial DNA (16S rDNA)